Therapeutic Effect of Oncolytic Herpes Simplex Virus Type 1 (G47Δ) in Combination with Chemotherapy on Colorectal Cancer

被引：1
|
作者：
Abe, Shinya [1 ]
Ino, Yasushi [1 ]
Fukuhara, Hiroshi [2 ]
Iwai, Miwako [1 ]
Watanabe, Toshiaki [3 ]
Todo, Tomoki [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Tokyo, Japan
[3] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33472-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
664
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
    Yamada, Tomoharu
    Tateishi, Ryosuke
    Iwai, Miwako
    Koike, Kazuhiko
    Todo, Tomoki
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 535 - 545
  • [22] THE EFFICACY OF ONCOLYTIC VIRUS THERAPY USING G47 Δ IN BILIARY TRACT CANCER
    Tateno, Yoko
    Ino, Yasushi
    Iwai, Miwako
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 908 - 908
  • [23] Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
    Sugawara, Kotaro
    Iwai, Miwako
    Yajima, Shoh
    Tanaka, Minoru
    Yanagihara, Kazuyoshi
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2020, 17 : 205 - 215
  • [24] Therapeutic effect on bladder cancer with a conditionally replicating oncolytic virus derived from herpes simplex virus type II
    Joo, Kwan Joong
    Yamashita, Hideyuki
    Li, Hongtao
    Zhang, Xiaoliu
    Lerner, Seth P.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 373 - 374
  • [25] Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus
    Joo, Kwan Joong
    Li, Hongtao
    Zhang, Xiaoliu
    Lerner, Seth P.
    BLADDER CANCER, 2015, 1 (01) : 81 - 90
  • [26] Intratumoral oncolytic herpes virus G47 increment for residual or recurrent glioblastoma: a phase 2 trial
    Todo, Tomoki
    Ito, Hirotaka
    Ino, Yasushi
    Ohtsu, Hiroshi
    Ota, Yasunori
    Shibahara, Junji
    Tanaka, Minoru
    NATURE MEDICINE, 2022, 28 (08) : 1630 - +
  • [27] Combination Therapy of Oncolytic Herpes Simplex Virus Type 1 with Erlotinib in a Human Lung Cancer Xenograft Model
    Sakata, Yoshinori
    Ino, Yasushi
    Todo, Tomoki
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1279 - S1279
  • [28] Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47? combination therapy against glioblastoma
    Chalise, Lushun
    Kato, Akira
    Ohno, Masasuke
    Maeda, Sachi
    Yamamichi, Akane
    Kuramitsu, Shunichiro
    Shiina, Satoshi
    Takahashi, Hiromi
    Ozone, Sachiko
    Yamaguchi, Junya
    Kato, Yukinari
    Rockenbach, Yumi
    Natsume, Atsushi
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2022, 26 : 265 - 274
  • [29] Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
    Yajima, Shoh
    Sugawara, Kotaro
    Iwai, Miwako
    Tanaka, Minoru
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2021, 23 : 402 - 411
  • [30] Efficacy of oncolytic herpes virus G47δ combined with immune checkpoint inhibitors in renal cell carcinoma models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2024, 115 : 648 - 648
12345